Nuclear Medicine Therapy

Luca Giovanella completed his doctoral degree at the Medical School of University of Pavia (I) in 1991. Subsequently, he obtained his post-graduate Degree in Nuclear Medicine (1995) and Endocrinology (2000) at the University of Milan, as well as an Executive Master in Health Organization and Human Resources Management (2000) at the Politecnico Universitario of Milan. He served as a consultant at the Department of Nuclear Medicine-University Hospital “Fondazione Macchi” of Varese from 1993 to 2002, and chaired the Thyroid Unit and the Laboratory for Endocrinology from 1995 to 2002. He serves as Chairman of the Clinic of Nuclear Medicine and Molecular Imaging and the Competence Centre for Thyroid Diseases at the Ente Ospedaliero Cantonale (EOC) in Bellinzona and Lugano (Switzerland) since 2003. He also serves as Scientific Advisor to the Department of Clinical Chemistry and Laboratory Medicine at EOC in Bellinzona. He served as Privat-Dozent (PD) from 2008 to 2014 and has been Titular Professor at the Institute of Nuclear Medicine, University of Zurich, since 2015. His clinical and scientific activities are mainly focused on the diagnosis and treatment of thyroid diseases as well as molecular imaging and theranostics

• Preface.- Acknowledgement.-Nuclear medicine theranostics: between atoms and patients.- Radioiodine therapy of benign thyroid diseases.- Radioiodine therapy of thyroid cancers.- Peptide radio-receptor therapy (pprt) of neuroendocrine tumors.- [I-131]-MIBG therapy of malignant pheochromocytomas and neuroblastoma.- Radiometabolic therapy of bone metastases.- Selective internal radiotherapy (sirt) of primary hepatic carcinoma and liver metastases.- Radioimmunotherapy of lymphomas.